Tzu-Ching Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tzu-Ching Wu has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Sean Isaac Savitz
From the Institute for Stroke and Cerebrovascular Disease, University of Texas Health Science Center (UTHealth), Houston
9 shared publications - Farhaan Shaheer Vahidy
Center for Health Outcomes and Informatics Research in Rehabilitation, TIRR Memorial Hermann, Houston, TX (A.T.B., E.F.L., F.S.V.).
7 shared publications - Christy Ankrom
Neurology, The Univ of Texas Health Science Cntr, Houston, TX
6 shared publications - Arvind B. Bambhroliya
Neurology, UT Health Science Cntr at Houston, Houston, TX
5 shared publications Sean I. Savitz
Institute for Stroke and Cerebrovascular Disease, Department of Neurology, Houston, Texas; University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas
5 shared publicationsJames C. Grotta
From the Department of Neurology (T.-C.W., S.A.P., A.J., R.B.) and Department of Biostatistics, School of Public Health (J.-M.Y.), University of Texas Health Science Center at Houston; Department of Neurology, Houston Methodist Neurological Institute (A.T.); University of Vermont College of Medicine (A.Y.); and Memorial Hermann Hospital (J.C.G.).
4 shared publications
Latest Publications
- Open Access
- 1 March 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (3) , 105602
IAT-TiMeS: Intra-Arterial Thrombectomy Transfer Metric Study in Texas
- 1 March 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (3) , 105602
Open AccessIAT-TiMeS: Intra-Arterial Thrombectomy Transfer Metric Study in Texas
- 1 January 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (1) , 105418
Lack of Racial, Ethnic, and Sex Disparities in Ischemic Stroke Care Metrics within a Tele-Stroke Network
- 1 January 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (1) , 105418
Lack of Racial, Ethnic, and Sex Disparities in Ischemic Stroke Care Metrics within a Tele-Stroke Network
- 1 November 2019
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 28 (11) , 104332
Variability and Delay in Telestroke Physician Alert among Spokes in a Telestroke Network: A Need for Metric Benchmarks
- 1 November 2019
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 28 (11) , 104332
Variability and Delay in Telestroke Physician Alert among Spokes in a Telestroke Network: A Need for Metric Benchmarks
- 1 November 2018
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 28 (1) , 198-204
No Weekend or After-Hours Effect in Acute Ischemic Stroke Patients Treated by Telemedicine
- 1 November 2018
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 28 (1) , 198-204
No Weekend or After-Hours Effect in Acute Ischemic Stroke Patients Treated by Telemedicine
- Open Access
- 21 March 2018
- Published by Springer Nature in BMC Neurology
- Vol. 18 (1) , 1-8
Rationale and Design of a Statewide Cohort to examine efficient resource utilization for patients with Intracerebral hemorrhage (EnRICH)
Intracerebral hemorrhage is a devastating disease with no specific treatment modalities. A significant proportion of patients with intracerebral hemorrhage are transferred to large stroke treatment centers, such as Comprehensive Stroke Centers, because of perceived need for higher level of care. However, evidence of improvement in patient-centered outcomes for these patients treated at larger stroke treatment centers as compared to community hospitals is lacking. “Efficient Resource Utilization for Patients with Intracerebral Hemorrhage (EnRICH)” is a prospective, multisite, state-wide, cohort study designed to assess the impact of level of care on long-term patient-centered outcomes for patients with primary / non-traumatic intracerebral hemorrhage. The study is funded by the Texas state legislature via the Lone Star Stroke Research Consortium. It is being implemented via major hub hospitals in large metropolitan cities across the state of Texas. Each hub has an extensive network of “spoke” hospitals, which are connected to the hub via traditional clinical and administrative arrangements, or by telemedicine technologies. This infrastructure provides a unique opportunity to track outcomes for intracerebral hemorrhage patients managed across a health system at various levels of care. Eligible patients are enrolled during hospitalization and are followed for functional, quality of life, cognitive, resource utilization, and dependency outcomes at 30 and 90 days post discharge. As a secondary aim, an economic analysis of the incremental cost-effectiveness of treating intracerebral hemorrhage patients at higher levels of care will be conducted. Findings from EnRICH will provide much needed evidence of the effectiveness and efficiency of regionalized care for intracerebral hemorrhage patients. Such evidence is required to inform policy and streamline clinical decision-making.
- 21 March 2018
- Published by Springer Nature in BMC Neurology
- Vol. 18 (1) , 1-8
Open AccessRationale and Design of a Statewide Cohort to examine efficient resource utilization for patients with Intracerebral hemorrhage (EnRICH)
Intracerebral hemorrhage is a devastating disease with no specific treatment modalities. A significant proportion of patients with intracerebral hemorrhage are transferred to large stroke treatment centers, such as Comprehensive Stroke Centers, because of perceived need for higher level of care. However, evidence of improvement in patient-centered outcomes for these patients treated at larger stroke treatment centers as compared to community hospitals is lacking. “Efficient Resource Utilization for Patients with Intracerebral Hemorrhage (EnRICH)” is a prospective, multisite, state-wide, cohort study designed to assess the impact of level of care on long-term patient-centered outcomes for patients with primary / non-traumatic intracerebral hemorrhage. The study is funded by the Texas state legislature via the Lone Star Stroke Research Consortium. It is being implemented via major hub hospitals in large metropolitan cities across the state of Texas. Each hub has an extensive network of “spoke” hospitals, which are connected to the hub via traditional clinical and administrative arrangements, or by telemedicine technologies. This infrastructure provides a unique opportunity to track outcomes for intracerebral hemorrhage patients managed across a health system at various levels of care. Eligible patients are enrolled during hospitalization and are followed for functional, quality of life, cognitive, resource utilization, and dependency outcomes at 30 and 90 days post discharge. As a secondary aim, an economic analysis of the incremental cost-effectiveness of treating intracerebral hemorrhage patients at higher levels of care will be conducted. Findings from EnRICH will provide much needed evidence of the effectiveness and efficiency of regionalized care for intracerebral hemorrhage patients. Such evidence is required to inform policy and streamline clinical decision-making.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract 158: Time to Decision and Treatment With Tissue Plasminogen Activator Using Telemedicine versus an On-board Physician on a Mobile Stroke Unit
Background: Mobile stroke units (MSU) can speed treatment with intravenous tissue plasminogen activator (tPA) for stroke patients. MSUs may use either an on-board (OB) or telemedicine (TM) based vascular neurologist (VN) for deciding tPA treatment. In the first phase of this study, we showed that agreement on giving tPA between a TM and OB-VN on a MSU is the same as between two VNs evaluating the same patient on site in the emergency department. In that phase, the actual treatment was determined by the OB-VN so that the TM-VN decision was delayed. In this phase, we determined the time from MSU arrival to tPA treatment decision and treatment when the TM-VN was the primary decision-maker and compared these to the same metrics for the OB-VN in the first phase. Methods: After MSU arrival on-scene, with the assistance of the OB nurse and paramedic, the TM-VN directed the evaluation of the patient, the CT scan was directly pushed to the TM-VN via a cloud-based picture archiving and communication system, and the TM-VN made the decision whether or not to treat. Times from MSU arrival to tPA decision and tPA bolus were compared to the same metrics for the OB-VN during the first phase of the study using a 2-sample t-test with log-transformation to satisfy t-test assumptions. Median times and interquartile range (IQR) were calculated for each group (Table 1). Results: The TM-VN was, on average, 3 minutes slower in making the tPA decision compared with the OB-VN (OB: 18 minutes [IQR 14-23] versus TM: 21 minutes [IQR 16-26], p=0.05). There was no difference however, in the time to tPA bolus between the two groups [OB: 23 minutes (IQR 19-30) versus TM: 24 minutes (IQR 19-28), p=0.70, with 95% confidence interval [-2.18-3.24]. Conclusion: A telemedicine based VN can treat a patient with tPA on a MSU as quickly as an on-board VN.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract 158: Time to Decision and Treatment With Tissue Plasminogen Activator Using Telemedicine versus an On-board Physician on a Mobile Stroke Unit
Background: Mobile stroke units (MSU) can speed treatment with intravenous tissue plasminogen activator (tPA) for stroke patients. MSUs may use either an on-board (OB) or telemedicine (TM) based vascular neurologist (VN) for deciding tPA treatment. In the first phase of this study, we showed that agreement on giving tPA between a TM and OB-VN on a MSU is the same as between two VNs evaluating the same patient on site in the emergency department. In that phase, the actual treatment was determined by the OB-VN so that the TM-VN decision was delayed. In this phase, we determined the time from MSU arrival to tPA treatment decision and treatment when the TM-VN was the primary decision-maker and compared these to the same metrics for the OB-VN in the first phase. Methods: After MSU arrival on-scene, with the assistance of the OB nurse and paramedic, the TM-VN directed the evaluation of the patient, the CT scan was directly pushed to the TM-VN via a cloud-based picture archiving and communication system, and the TM-VN made the decision whether or not to treat. Times from MSU arrival to tPA decision and tPA bolus were compared to the same metrics for the OB-VN during the first phase of the study using a 2-sample t-test with log-transformation to satisfy t-test assumptions. Median times and interquartile range (IQR) were calculated for each group (Table 1). Results: The TM-VN was, on average, 3 minutes slower in making the tPA decision compared with the OB-VN (OB: 18 minutes [IQR 14-23] versus TM: 21 minutes [IQR 16-26], p=0.05). There was no difference however, in the time to tPA bolus between the two groups [OB: 23 minutes (IQR 19-30) versus TM: 24 minutes (IQR 19-28), p=0.70, with 95% confidence interval [-2.18-3.24]. Conclusion: A telemedicine based VN can treat a patient with tPA on a MSU as quickly as an on-board VN.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract TP310: Inter- Rater Reliability of Telephonic Modified Rankin Scale Obtained for a Telestroke Network
Introduction: The modified Rankin Scale (mRS) has been established as a standard measurement of stroke disability and is widely used in major stroke clinical trials. Previous studies compared inter-rater reliability between face-to-face and telephone assessments; we aimed to evaluate the reliability of the mRS between two rater’s assessments both conducted by telephone. Objective: Identify the inter-rater reliability of mRS of patients interviewed twice by mRS-certified raters over telephone. Methods: Patients seen by telemedicine (TM) between 03/2017-04/2017 at UTHealth Lone Star Stroke Consortium spoke sites with discharge diagnosis of ischemic or hemorrhagic stroke and contacted via telephone. They underwent a structured telephone interview conducted by two trained raters of the UTHealth TM research team. The 2 interviews were conducted within 2 weeks of each other. Scoring agreement was measured using the κ statistic. Results: Total of 65 patients were in-window for 90 day mRS telephone interviews; excluding deaths, mRS of 30 patients were collected by both interviewers. The overall agree ment between two raters was 43.3% (13 cases). It was most common to disagree by one category (10 cases, 33.3%). The unweighted kappa value (κ) for inter-rater agreement was 0.29 (p = 0.0006), and the weighted kappa value (κ w ) was 0.50 (p = 0.0000). Conclusion: Unlike previous studies, we found reliability of mRS obtained via structured telephone interview in our TM population is uncertain. The inter-rater reliability of mRS assessed by telephone shows discrepancies between interviewers, as >50% of patients did not receive the same score. Our study is limited by small sample size and further studies are needed to confirm our findings. With clinical trials relying on telephone mRS for longitudinal measurement of patient outcome and some requiring mRS on the same patient multiple times during a study, it is important mRS be both reliable and reproducible between different raters.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract TP310: Inter- Rater Reliability of Telephonic Modified Rankin Scale Obtained for a Telestroke Network
Introduction: The modified Rankin Scale (mRS) has been established as a standard measurement of stroke disability and is widely used in major stroke clinical trials. Previous studies compared inter-rater reliability between face-to-face and telephone assessments; we aimed to evaluate the reliability of the mRS between two rater’s assessments both conducted by telephone. Objective: Identify the inter-rater reliability of mRS of patients interviewed twice by mRS-certified raters over telephone. Methods: Patients seen by telemedicine (TM) between 03/2017-04/2017 at UTHealth Lone Star Stroke Consortium spoke sites with discharge diagnosis of ischemic or hemorrhagic stroke and contacted via telephone. They underwent a structured telephone interview conducted by two trained raters of the UTHealth TM research team. The 2 interviews were conducted within 2 weeks of each other. Scoring agreement was measured using the κ statistic. Results: Total of 65 patients were in-window for 90 day mRS telephone interviews; excluding deaths, mRS of 30 patients were collected by both interviewers. The overall agree ment between two raters was 43.3% (13 cases). It was most common to disagree by one category (10 cases, 33.3%). The unweighted kappa value (κ) for inter-rater agreement was 0.29 (p = 0.0006), and the weighted kappa value (κ w ) was 0.50 (p = 0.0000). Conclusion: Unlike previous studies, we found reliability of mRS obtained via structured telephone interview in our TM population is uncertain. The inter-rater reliability of mRS assessed by telephone shows discrepancies between interviewers, as >50% of patients did not receive the same score. Our study is limited by small sample size and further studies are needed to confirm our findings. With clinical trials relying on telephone mRS for longitudinal measurement of patient outcome and some requiring mRS on the same patient multiple times during a study, it is important mRS be both reliable and reproducible between different raters.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract TP278: Decade-Long Trends in Recanalization Therapy at a Large Regional Comprehensive Stroke Center in Texas
Introduction: Recanalization therapy (RT) is the cornerstone of acute ischemic stroke (AIS) management. We present 10-year trend in RT at our center, and explore effects of increasing telemedicine (TM) access and a Mobile Stroke Unit (MSU). Methods: We identified suspected AIS patients between 01/01/2007-12/31/2016 from our prospectively managed registry. Patients presented directly (DP), were transferred-in (TP) from a regional referring hospital with or without TM consultation, or via the MSU. Pre-established TM/MSU period was from 01/01/2007-12/31/2011. We used logistic regression to explore temporal trends among patient groups, report odds ratios (OR) with 95% confidence intervals, and quantile regression to determine the difference in median (DIM) treatment times. Results: We reviewed 9,464 suspected AIS cases. 44.8% were in pre-TM/MSU and 55.2% TM/MSU period. Over 10 years, the proportion of DP has significantly reduced [OR 0.84 (0.83-0.86)], whereas non-TM TP has increased [OR 1.05 (1.03-1.06)]. In TM/MSU period, the proportion of TM patients has significantly increased each year [OR 2.00 (1.85-2.16)]. Fig. 1 shows the proportional distribution. 29.3% of patients were treated with tPA; significantly higher during the TM/MSU period compared to pre-TM/MSU [(31.5% vs 21.5%, OR 1.21 (1.11 - 1.33)]. Median onset to needle time was significantly shorter for the TM/MSU period [140(99-193) vs 157(119-198), DIM -17(-10.7,-23.2)], as was the proportion of symptomatic intracranial hemorrhage (sICH) [(1.7% vs 4.2%), OR 0.40(0.25-0.64)]. With each increasing year, a significantly greater proportion of patients were discharged home after controlling for age and NIHSS [OR 1.12 (1.10-1.14)]. Conclusion: Over a decade, we saw a steady increase in proportion of tPA treated cases. With the introduction of TM and the MSU at our institution, more AIS patients received RT, with faster onset to treatment, fewer sICH complications, and improved discharge disposition.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract TP278: Decade-Long Trends in Recanalization Therapy at a Large Regional Comprehensive Stroke Center in Texas
Introduction: Recanalization therapy (RT) is the cornerstone of acute ischemic stroke (AIS) management. We present 10-year trend in RT at our center, and explore effects of increasing telemedicine (TM) access and a Mobile Stroke Unit (MSU). Methods: We identified suspected AIS patients between 01/01/2007-12/31/2016 from our prospectively managed registry. Patients presented directly (DP), were transferred-in (TP) from a regional referring hospital with or without TM consultation, or via the MSU. Pre-established TM/MSU period was from 01/01/2007-12/31/2011. We used logistic regression to explore temporal trends among patient groups, report odds ratios (OR) with 95% confidence intervals, and quantile regression to determine the difference in median (DIM) treatment times. Results: We reviewed 9,464 suspected AIS cases. 44.8% were in pre-TM/MSU and 55.2% TM/MSU period. Over 10 years, the proportion of DP has significantly reduced [OR 0.84 (0.83-0.86)], whereas non-TM TP has increased [OR 1.05 (1.03-1.06)]. In TM/MSU period, the proportion of TM patients has significantly increased each year [OR 2.00 (1.85-2.16)]. Fig. 1 shows the proportional distribution. 29.3% of patients were treated with tPA; significantly higher during the TM/MSU period compared to pre-TM/MSU [(31.5% vs 21.5%, OR 1.21 (1.11 - 1.33)]. Median onset to needle time was significantly shorter for the TM/MSU period [140(99-193) vs 157(119-198), DIM -17(-10.7,-23.2)], as was the proportion of symptomatic intracranial hemorrhage (sICH) [(1.7% vs 4.2%), OR 0.40(0.25-0.64)]. With each increasing year, a significantly greater proportion of patients were discharged home after controlling for age and NIHSS [OR 1.12 (1.10-1.14)]. Conclusion: Over a decade, we saw a steady increase in proportion of tPA treated cases. With the introduction of TM and the MSU at our institution, more AIS patients received RT, with faster onset to treatment, fewer sICH complications, and improved discharge disposition.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract WP323: Using Telemedicine Eliminates the Weekend After-Hours Effect in Acute Ischemic Stroke Patients
Background: Stroke outcomes have been shown to be worse for patients presenting overnight and on weekends (off-hours) to stroke centers compared with those presenting during business hours (on-hours). Not all stroke patients present to stroke centers. Telemedicine (TM) helps provide evaluation and safe management of stroke patients. The UT Teleneurology (UTT) hub provides acute neurological coverage by stroke specialists to 19 spoke centers. To our knowledge, variation in patient care and outcomes based on time of hospital presentation has not been thoroughly studied in stroke patients managed via TM. Objective: Compare time metrics and outcomes of stroke patients who were assessed and received IV-tPA via TM during off-hours with those during on-hours. Methods: In a retrospective query of the UTT registry from 9/15 - 12/16, we identified 425 stroke patients who were assessed via TM and received IV-tPA - 424 were included in our analysis, one was excluded after quality check. We compared baseline characteristics, clinical variables, time metrics, and outcomes between the off-hours (5pm-7:59am, weekends) and on-hours (weekdays 8am-4:59pm) patients (Table 1). Result: Of the 424 patients, 268 were managed via TM during off-hours, and 156 during on-hours. Baseline characteristics and clinical variables were similar between the groups. Importantly, there were no differences in all relevant time metrics including door to needle time. IV-tPA complications (including all ICH, any systemic bleeding, and angioedema), discharge disposition, and 90-day mRS were also similar in the groups. Conclusion: There was no difference in clinical outcomes between the patients treated off-hours vs on-hours. Unlike in-person neurology coverage at many centers, the coverage provided by UTT does not differ depending on the hour or day. Access to stroke specialists 24/7 via TM can ensure uniform and rapid clinical care for acute stroke patients regardless of the time of day or day of the week.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract WP323: Using Telemedicine Eliminates the Weekend After-Hours Effect in Acute Ischemic Stroke Patients
Background: Stroke outcomes have been shown to be worse for patients presenting overnight and on weekends (off-hours) to stroke centers compared with those presenting during business hours (on-hours). Not all stroke patients present to stroke centers. Telemedicine (TM) helps provide evaluation and safe management of stroke patients. The UT Teleneurology (UTT) hub provides acute neurological coverage by stroke specialists to 19 spoke centers. To our knowledge, variation in patient care and outcomes based on time of hospital presentation has not been thoroughly studied in stroke patients managed via TM. Objective: Compare time metrics and outcomes of stroke patients who were assessed and received IV-tPA via TM during off-hours with those during on-hours. Methods: In a retrospective query of the UTT registry from 9/15 - 12/16, we identified 425 stroke patients who were assessed via TM and received IV-tPA - 424 were included in our analysis, one was excluded after quality check. We compared baseline characteristics, clinical variables, time metrics, and outcomes between the off-hours (5pm-7:59am, weekends) and on-hours (weekdays 8am-4:59pm) patients (Table 1). Result: Of the 424 patients, 268 were managed via TM during off-hours, and 156 during on-hours. Baseline characteristics and clinical variables were similar between the groups. Importantly, there were no differences in all relevant time metrics including door to needle time. IV-tPA complications (including all ICH, any systemic bleeding, and angioedema), discharge disposition, and 90-day mRS were also similar in the groups. Conclusion: There was no difference in clinical outcomes between the patients treated off-hours vs on-hours. Unlike in-person neurology coverage at many centers, the coverage provided by UTT does not differ depending on the hour or day. Access to stroke specialists 24/7 via TM can ensure uniform and rapid clinical care for acute stroke patients regardless of the time of day or day of the week.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract TMP73: Rehabilitation for Patients With Primary Intracerebral Hemorrhage is Associated With Reduced 30-Day Hospital Readmissions
Introduction: Readmission (RA) after stroke is an established quality of care metric and is tied to reimbursements. Administrative databases lack stroke-specific severity indicators and information on post-discharge mortality. We report the cumulative incidence of 30-day RA for patients with primary intracerebral hemorrhage (ICH) from a statewide prospective cohort. Methods: Eligible ICH patients are consented to participate in the cohort to assess the impact of level of care on patient-centered outcomes across Texas. Patients undergo inpatient evaluation, followed by 30- and 90-day assessments for functional, cognitive, quality of life, dependency, and resource utilization outcomes. We defined 30-day RA as any RA that was assessed 30 days post-acute care hospitalization for the index ICH event. We used survival analyses to provide hazard ratios (HR) and 95% confidence interval (CI), while modeling post-discharge mortality as a competing risk. Results: Thus far, 158 patients have been enrolled with RA information available for 104. The overall RA rate is 5.1 / 1000 person-days (CI: 3.1-8.3). Among the various factors evaluated (Table 1), 30-day RA is significantly higher for patients with a higher ICH score (HR: 5.67, CI: 1.45-22.19), whereas post-discharge rehabilitation (as compared to discharge to home) appears to reduce the risk of RA, even after accounting for institution-free period of observation (HR: 0.11, CI: 0.01-0.86). Among patients with a high ICH score, those discharged home had significantly higher risk of RA as compared to those who received rehabilitation (Figure 1). Enrollment is continuing; updated analyses will be presented. Conclusion: Stroke-specific disease severity factors are important to identify to develop effective preventive strategies against RA, and need to be controlled for when comparing RA metrics across patient populations. Influence of post-stroke rehab on curtailing RA for ICH patients needs to be explored further.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract TMP73: Rehabilitation for Patients With Primary Intracerebral Hemorrhage is Associated With Reduced 30-Day Hospital Readmissions
Introduction: Readmission (RA) after stroke is an established quality of care metric and is tied to reimbursements. Administrative databases lack stroke-specific severity indicators and information on post-discharge mortality. We report the cumulative incidence of 30-day RA for patients with primary intracerebral hemorrhage (ICH) from a statewide prospective cohort. Methods: Eligible ICH patients are consented to participate in the cohort to assess the impact of level of care on patient-centered outcomes across Texas. Patients undergo inpatient evaluation, followed by 30- and 90-day assessments for functional, cognitive, quality of life, dependency, and resource utilization outcomes. We defined 30-day RA as any RA that was assessed 30 days post-acute care hospitalization for the index ICH event. We used survival analyses to provide hazard ratios (HR) and 95% confidence interval (CI), while modeling post-discharge mortality as a competing risk. Results: Thus far, 158 patients have been enrolled with RA information available for 104. The overall RA rate is 5.1 / 1000 person-days (CI: 3.1-8.3). Among the various factors evaluated (Table 1), 30-day RA is significantly higher for patients with a higher ICH score (HR: 5.67, CI: 1.45-22.19), whereas post-discharge rehabilitation (as compared to discharge to home) appears to reduce the risk of RA, even after accounting for institution-free period of observation (HR: 0.11, CI: 0.01-0.86). Among patients with a high ICH score, those discharged home had significantly higher risk of RA as compared to those who received rehabilitation (Figure 1). Enrollment is continuing; updated analyses will be presented. Conclusion: Stroke-specific disease severity factors are important to identify to develop effective preventive strategies against RA, and need to be controlled for when comparing RA metrics across patient populations. Influence of post-stroke rehab on curtailing RA for ICH patients needs to be explored further.